Lai Wang, Global Head of R&D at BeiGene, Ltd. (BGNE), sold 910 shares at $362.48 ($330K) on 2021-06-28, disclosed to the SEC on 2021-06-30.
Open-market sale of $330k BGNE by Global Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $362.48 | 455 | $165K | 50.0% |
| 2 | $362.48 | 455 | $165K | 50.0% |
| Total | $362.48 avg | 910 | $330K | 100% |
| Filing → |
| ONC | SELL | 2026-06-15 | $197K | — | Filing → |
| ONC | SELL | 2026-06-10 | $368K | — | Filing → |
| ONC | SELL | 2025-09-11 | $1.8M | — | Filing → |